Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 310 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1492. Clear
Clear
Q1
OTSUKA AMERICA PHARMACEUTICAL, INC. for OTSUKA AMERICA PHARMACEUTICAL, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Maryland · House · Senate
Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code, Veterans
View →
Q1
THE NICKLES GROUP, LLC for NOVO NORDISK, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $80,000.00 income
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q1
ADVANCED POLICY CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $40,000.00 income
Health Issues
View →
Q1
E3 STRATEGIC CONSULTING GROUP for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $50,000.00 income
Pharmacy
View →
Q1
HEALTHCARE LEADERSHIP COUNCIL for HEALTHCARE LEADERSHIP COUNCIL
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid
View →
Q1
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate
Health Issues
View →
Q1
DAVE KOLBE CONSULTING for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · $30,000.00 income
Pharmacy
View →
Q1
PUBLIC CITIZEN for PUBLIC CITIZEN
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Banking, Budget/Appropriations, Civil Rights/Civil Liberties, Consumer Issues/Safety/Products
View →
Q1
ELITE STRATEGIC SERVICES for CONSERVATIVES FOR PROPERTY RIGHTS
1st Quarter (Jan 1 - Mar 31) 2025 · South Carolina · House · Senate · $25,000.00 income
Copyright/Patent/Trademark, Health Issues, Labor Issues/Antitrust/Workplace, Taxation/Internal Revenue Code
View →
Q1
AEGIS LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Health Issues
View →
Previous Page 13 of 13

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem